Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastasis: symptom/tumor marker-based versus CT-based.

Hiroko Hasegawa; Kazumasa Fujitani; Shoichi Nakazuru; Motohiro Hirao; Kazuyoshi Yamamoto; Eiji Mita; Toshimasa Tsujinaka

首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastasis: symptom/tumor marker-based versus CT-based.

【24h】

Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastasis: symptom/tumor marker-based versus CT-based.

机译：未测量腹膜转移的晚期胃癌的最佳处理改变标准：症状/肿瘤标志物与CT基于CT的基于CT。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The present study suggests that aggravated clinical symptoms/elevated TMs could be a sensitive predictor for disease progression in patients with AGC with non-measurable peritoneal metastasis.

机译：本研究表明，加剧的临床症状/升高的TMS可以是AGC具有非可测量腹膜转移的AGC患者疾病进展的敏感预测因子。

著录项

来源
《Anticancer Research: International Journal of Cancer Research and Treatment》 |2014年第9期|共6页
作者
Hiroko Hasegawa; Kazumasa Fujitani; Shoichi Nakazuru; Motohiro Hirao; Kazuyoshi Yamamoto; Eiji Mita; Toshimasa Tsujinaka;
展开▼
作者单位

Department of Surgery Kaizuka City Hospital Kaizuka Osaka Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastasis: symptom/tumor marker-based versus CT-based. [J] . Hiroko Hasegawa, Kazumasa Fujitani, Shoichi Nakazuru, Anticancer Research: International Journal of Cancer Research and Treatment . 2014,第9期

机译：未测量腹膜转移的晚期胃癌的最佳处理改变标准：症状/肿瘤标志物与CT基于CT的基于CT。
2. Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. [J] . Hirose K, Katayama K, Iida A, Oncology: International Journal of Cancer Research and Treatment . 1999,第2期

机译：持续高温腹膜灌注对预防和治疗晚期胃癌腹膜转移的疗效：通过多元回归分析进行评估。
3. Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. [J] . Imamoto H, Oba K, Sakamoto J, Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2011,第1期

机译：评估具有不可测量病灶的胃恶性腹水的临床获益反应：紫杉醇治疗晚期/复发胃癌继发性恶性腹水的多中心II期临床试验。
4. Prophylaxis and Treatment of Advanced Gastric Cancer with Peritoneal Metastasis with Intraperitoneal(I.P.) Administration of Liposome-Carboplatin(Lipo-CBDCA) and Its Clinical Trial in Peritoneal Carcinomatosis(P.C.). [C] . Mizuno I., Yotsuyanagi T., Ishida M., International Gastric Cancer Congress . 2011

机译：腹膜内（I.P，I.P）对腹膜转移的预防和治疗晚期胃癌（I.P。）脂质体 - 卡铂（Lipo-CBDCA）的施用及其在腹膜癌症中的临床试验（P.C。）。
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. Treatment options for advanced gastric cancer with peritoneal metastasis: experience from a single institution in Korea [O] . Dong-Wook Kim, Sang Il Youn, Ye Seob Jee 2021

机译：腹膜转移的晚期胃癌治疗选择：韩国单一机构的经验
7. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer [O] . Dong-Wook Kim, Dong-Guk Park, Sanghyun Song, 2018

机译：细胞导致手术和高温腹腔化疗作为治疗晚期胃癌腹膜转移的治疗选择

Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastasis: symptom/tumor marker-based versus CT-based.

摘要

著录项

相似文献

相关主题

期刊订阅